Innovent Biologics

Innovent Biologics,Inc. is a leading biopharmaceutical company in China focused on the discovery, development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMA and FDA/cGMP standards. Innovent has an expanding biologics pipeline focused on oncology, inflammatory diseases and ophthalmology. Innovent's strategy is to advance its internal pipeline of proprietary biologic drugs and establish in/out-licensing agreements with global pharmaceutical/biotech companies. Because of its location and emphasis on quality, Innovent is able to leverage China's cost-efficient environment without compromising its world-class quality standards.
Company growth
Type
Private
HQ
Suzhou, CN
Founded
2011
Size (employees)
99 (est)-1%
Innovent Biologics was founded in 2011 and is headquartered in Suzhou, CN

Innovent Biologics Office Locations

Innovent Biologics has office in Suzhou
Suzhou, CN

Innovent Biologics Metrics

Innovent Biologics Summary

We estimate that Innovent Biologics's latest funding round in November 2016 was $260 M. In total, Innovent Biologics has raised $385 M

Market Position – drug development, healthtech, biotech, manufacturer, pharma, Health

Innovent Biologics Company Life

You may also be interested in